Nasdaq
$0.5950▼ 2.23%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $81.1MShares out 1.400M sh
Chart
Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
Filings
11- 9.29After-hours26.09.30 05:424Ownership#●●●
Rani Therapeutics Holdings, Inc.
Insider Imran Talat of Rani Therapeutics Holdings, Inc. reported a change in beneficial ownership of securities as of September 27, 2026. This filing formalizes the insider's transaction activity via Form 4.…more
$0.5950-2.23%vs prev closeDetected5m · 30m · 60m · Next dayPLUSView filingShare
- 9.29After-hours26.09.30 05:364Ownership
Rani Therapeutics Holdings, Inc.
Insider Alireza Javadi of Rani Therapeutics Holdings, Inc. reported a change in beneficial ownership of securities as of September 27, 2026. This filing is a standard disclosure of insider equity transactions via Form 4.…more
$0.5950-2.23%vs prev closeView filingShare - 8.5Overnight26.08.05 09:514Ownership
Rani Therapeutics Holdings, Inc.
Rani Therapeutics Holdings, Inc.의 내부자인 Michelle Gilson이 2026년 8월 3일자로 주식 보유 현황 변동을 보고하는 Form 4를 제출했습니다. 해당 공시는 내부자의 지분 변동 사항을 공식적으로 기록한 문서입니다.…more
$0.5950-2.23%vs prev closeView filingShare
10 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report
News
GlobeNewswire- 10.13After-hours26.10.14 05:05#●●●#●●●
Rani Therapeutics to Participate in Chardan Healthcare Conference
Rani Therapeutics announced that its management team will participate in a fireside chat and investor meetings at the upcoming Chardan Healthcare Conference. This is a routine investor relations event and does not contain material financial news.…more
$0.5950-2.23%vs prev closeDetected5m · 30m · 60m · Next dayPLUS
- 10.5Pre-market26.10.05 21:00
●●●●●●●● ●●●●● ●●●●●●
Rani Therapeutics' RaniPill platform has been accepted into the FDA's Emerging Technology Program to facilitate early engagement on technical and regulatory matters. While this supports development, it does not constitute product approval or immediate financial impact, maintaining a neutral outlook.…more
$0.5950-2.23%vs prev close - 8.10Pre-market26.08.10 21:00
●●●●●●●● ●●●●● ●●●●●●
라니 테라퓨틱스 경영진이 캐너코드 제뉴이티 주관 제46회 연례 성장 컨퍼런스에 참석해 기업 발표와 투자자 미팅을 진행합니다. 이번 행사를 통해 경구용 생물학적 제제 전달 기술인 라니필 플랫폼의 성과를 알릴 예정입니다.…more
$0.5950-2.23%vs prev close
2 more news items
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report